Trial Details
COMPLETEDBasic Information
| Clinical ID | c1612 |
|---|---|
| Identifier | NCT02819635 |
| Trial Title | A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: Placebo|DRUG: Upadacitinib |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2016-09-26 |
|---|---|
| Primary Completion Date | 2021-12-13 |
| Completion Date | 2021-12-13 |